Biweekly Docetaxel in Patients With Metastatic Breast Cancer.

NCT02041351 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Docetaxel

Sponsor

Centro Universitario contra el Cáncer